|
|
Hans D. Ochs, Starkey D. Davis, Ralph J. Wedgwood
J Clin Invest. 1971;
50(12):2559
doi:10.1172/JCI106756
Abstract |
Full text
| PDF
I
mmunologic responses to bacteriophage ϕX 174 were studied in 26 patients with immunodeficiency diseases. In eight cases of infantile X-linked agammaglobulinemia, there was prolonged circulation of phage and no detectable antibody response. The remaining 18 patients cleared phage normally and produced antibodies. 10 of these patients made only IgM antibody in spite of repeated immunization; all of these have recurrent respiratory tract infections and require treatment with gamma globulin and antibiotics. Eight patients made both IgM and IgG antibody; they experience either milder or no infections, and only one requires treatment with gamma globulin.Prolonged circulation of bacteriophage ϕX 174 and the absence of a detectable antibody response appear to be distinguishing characteristics of X-linked agammaglobulinemia if severe combined immunodeficiency can be excluded.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(47)
| Title and authors |
Publication |
Year |
Antibody forming cells and plasmablasts in peripheral blood in CVID patients after vaccination
Zita Chovancova, Marcela Vlkova, Jiri Litzman, Jindrich Lokaj, Vojtech Thon
|
Vaccine
|
2011 |
Effect of rituximab on human in vivo antibody immune responses
Mark D. Pescovitz, Troy R. Torgerson, Hans D. Ochs, Elizabeth Ocheltree, Paula McGee, Heidi Krause-Steinrauf, John M. Lachin, Jennifer Canniff, Carla Greenbaum, Kevan C. Herold, Jay S. Skyler, Adriana Weinberg
|
Journal of Allergy and Clinical Immunology
|
2011 |
Heterozygous signal transducer and activator of transcription 3 mutations in hyper-IgE syndrome result in altered B-cell maturation
Almut Meyer-Bahlburg, Ellen D. Renner, Stacey Rylaarsdam, Janine Reichenbach, Lena F. Schimke, Amy Marks, Haig Tcheurekdjian, Robert Hostoffer, Archana Brahmandam, Troy R. Torgerson
|
Journal of Allergy and Clinical Immunology
|
2011 |
Vaccination against tick-borne encephalitis virus tests specific IgG production ability in patients under immunoglobulin substitution therapy
Markus G. Seidel, Eva Grohmann, Kambis Sadeghi, Arnold Pollak, Andreas Heitger, Elisabeth Förster-Waldl
|
Vaccine
|
2010 |
Bacteriophage therapy for Staphylococcus aureus bacteremia in streptozotocin-induced diabetic mice
Raju Sunagar, Shripad A. Patil, R. Kelmani Chandrakanth
|
Research in Microbiology
|
2010 |
A Short Burst of Oral Corticosteroid for Children with Acute Asthma: Is There an Impact on Immunity?
Francine M. Ducharme, Hans D. Ochs, Sandy Resendes, Xun Zhang, Bruce D. Mazer
|
Pediatric Allergy, Immunology, and Pulmonology
|
2010 |
The Use of Immunoglobulin Therapy for Patients With Primary Immune Deficiency: An Evidence-Based Practice Guideline
Nadine Shehata, Valerie Palda, Tom Bowen, Elie Haddad, Thomas B. Issekutz, Bruce Mazer, Robert Schellenberg, Richard Warrington, David Easton, David Anderson, Heather Hume
|
Transfusion Medicine Reviews
|
2010 |
Oligoclonality, impaired class switch and B-cell memory responses in WHIM syndrome.
Peter J Mc Guire, Charlotte Cunningham-Rundles, Hans Ochs, George A Diaz
|
Clin. Immunol.
|
2010 |
Bacteriophage biocontrol in animals and meat products
R. J. Atterbury
|
Microbial Biotechnology
|
2009 |
Immunologic reconstitution during PEG-ADA therapy in an unusual mosaic ADA deficient patient
Ping Liu, Ines Santisteban, Lauri M. Burroughs, Hans D. Ochs, Troy R. Torgerson, Michael S. Hershfield, David J. Rawlings, Andrew M. Scharenberg
|
Clinical Immunology
|
2009 |
|